These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9226634)

  • 1. Plasma renin activity and metabolic clearance rate of angiotensin II in the unstressed aging rat.
    Baylis C; Engels K; Hymel A; Navar LG
    Mech Ageing Dev; 1997 Aug; 97(2):163-72. PubMed ID: 9226634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system in conscious newborn sheep: metabolic clearance rate and activity.
    Velaphi SC; Despain K; Roy T; Rosenfeld CR
    Pediatr Res; 2007 Jun; 61(6):681-6. PubMed ID: 17426651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor-stimulated renin release is blunted in old rats.
    Baylis C; Engels K; Beierwaltes WH
    J Am Soc Nephrol; 1998 Jul; 9(7):1318-20. PubMed ID: 9644645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme determines plasma clearance of angiotensin-(1-7).
    Yamada K; Iyer SN; Chappell MC; Ganten D; Ferrario CM
    Hypertension; 1998 Sep; 32(3):496-502. PubMed ID: 9740616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat.
    Baylis C
    Am J Kidney Dis; 1993 Dec; 22(6):842-50. PubMed ID: 8250031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of proximal tubules to angiotensin II changes during maturation.
    Garvin JL; Beierwaltes WH
    Hypertension; 1998 Jan; 31(1 Pt 2):415-20. PubMed ID: 9453338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].
    Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo.
    Castoldi G; di Gioia CR; Pieruzzi F; van De Greef WM; Busca G; Sperti G; Stella A
    J Hypertens; 2001 Nov; 19(11):2011-8. PubMed ID: 11677366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR; Hui KY; Coletti C; Hollenberg NK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1993 Oct; 22(4):513-22. PubMed ID: 8406656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of angiotensin-generating systems in the developing rat kidney.
    Yosipiv IV; el-Dahr SS
    Hypertension; 1996 Feb; 27(2):281-6. PubMed ID: 8567053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical hemodynamic and hormonal responses to 14-day infusions of renin or angiotensin II in conscious rats.
    Hu L; Catanzaro DF; Pitarresi TM; Laragh JH; Sealey JE
    J Hypertens; 1998 Sep; 16(9):1285-98. PubMed ID: 9746116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H; Palmgren E; Widgren B; Aurell M
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.